Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Glycerol

Copy Product Info
😃Good
Catalog No. T4776Cas No. 56-81-5
Alias Glycerin

Glycerol is an important component of triglycerides (fats and oils) and phospholipids. It is widely used in the food industry as a sweetener, humectant, and in pharmaceutical formulations. Additionally, glycerol is used in sample preparation and gel formation for polyacrylamide gel electrophoresis and can be employed to induce acute kidney injury models.

Glycerol

Glycerol

Copy Product Info
😃Good
Purity: 99.98%
Catalog No. T4776Alias GlycerinCas No. 56-81-5
Glycerol is an important component of triglycerides (fats and oils) and phospholipids. It is widely used in the food industry as a sweetener, humectant, and in pharmaceutical formulations. Additionally, glycerol is used in sample preparation and gel formation for polyacrylamide gel electrophoresis and can be employed to induce acute kidney injury models.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
100 mL$41-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.98%
Color:Transparent
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Glycerol is an important component of triglycerides (fats and oils) and phospholipids. It is widely used in the food industry as a sweetener, humectant, and in pharmaceutical formulations. Additionally, glycerol is used in sample preparation and gel formation for polyacrylamide gel electrophoresis and can be employed to induce acute kidney injury models.
Disease Modeling Protocol
Acute Renal Failure(ARF) model
  • Modeling Mechanism:

    Glycerol induces rhabdomyolysis, releasing large amounts of myoglobin into the bloodstream. This myoglobin deposits in the proximal tubules of the kidney, forming casts that obstruct the tubules. Simultaneously, it triggers oxidative stress (increased malondialdehyde (MDA) and decreased nitrite levels in kidney tissue), activates the inflammatory response (upregulation of IL-1β expression) and the apoptosis pathway (activation of caspase-3), leading to vacuolar degeneration and coagulative necrosis of renal tubular epithelial cells, ultimately resulting in acute renal failure.

  • Related Products:

    Glycerol (T4776)

  • Modeling Method:

    Experimental Subject:

    Rats, Albino rats, Male, Body weight 150–250 g

    Dosage and Administration Route:

    ① Pre-treatment: 24-hour fasting prior to modelling (dehydrated state);
    ② Core modelling: 50% glycerol solution, 8 ml/kg, deep intramuscular injection (i.m.) into both hindlimbs;
    ③ Control treatment: Control rats injected with equal volume saline solution; all other procedures identical

    Dosing Frequency and Duration Model:

    Single dose

  • Validation:

    1. Functional Indicators: - Renal Function: Serum creatinine and blood urea nitrogen (BUN) were significantly elevated (p<0.0001); - Urine Indicators: Urinary albumin, urinary glucose, and urinary ketone body levels were significantly increased (p<0.0001); 2. Molecular Indicators: - Oxidative Stress: MDA levels in renal tissue were elevated, while nitrite levels were decreased (p<0.0001); - Renal Injury Markers: The expression of renal injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) in renal tissue was significantly upregulated (p<0.0001); - Inflammation and Apoptosis: Immunohistochemistry showed significantly increased positive expression of IL-1β and caspase-3 in renal tissue (p<0.05); 3. Pathological Indicators: - HE staining showed severe vacuolar degeneration and coagulative necrosis of proximal tubular epithelial cells, destruction of renal tubular structure, and nuclear pyknosis or dissolution (lesions involved 5-6 sections, score +++).

*Precautions: Inhalation of 5% isoflurane euthanized rats.

*References:Sabra MS,et,al. Sildenafil and furosemide nanoparticles as a novel pharmacological treatment for acute renal failure in rats. Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7865-7879.

SynonymsGlycerin
Chemical Properties
Molecular Weight92.09
FormulaC3H8O3
Cas No.56-81-5
SmilesOCC(O)CO
Relative Density.1.261 g/ml. Temperature:20 °C.
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
H2O: >500 mg/mL, Sonication is recommended.
DMSO: 300 mg/mL (3257.68 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM10.8589 mL54.2947 mL108.5894 mL542.9471 mL
5 mM2.1718 mL10.8589 mL21.7179 mL108.5894 mL
10 mM1.0859 mL5.4295 mL10.8589 mL54.2947 mL
20 mM0.5429 mL2.7147 mL5.4295 mL27.1474 mL
50 mM0.2172 mL1.0859 mL2.1718 mL10.8589 mL
100 mM0.1086 mL0.5429 mL1.0859 mL5.4295 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Glycerol | purchase Glycerol | Glycerol cost | order Glycerol | Glycerol chemical structure | Glycerol formula | Glycerol molecular weight